p38 Mitogen-Activated Protein Kinase Mediates the Sustained Phase of Hypoxic Pulmonary Vasoconstriction and Plays a Role in Phase I Vasodilation

Eric D. Morrell, Ben M. Tsai, Meijing Wang, Paul R. Crisostomo, Daniel R. Meldrum

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Hypoxic pulmonary vasoconstriction (HPV) and pulmonary hypertension present common and formidable clinical problems for thoracic, transplant, and trauma surgeons. We hypothesized that acute hypoxia causes pulmonary artery (PA) contraction and that p38 mitogen-activated protein (MAP) kinase is a key mediator in that process. To test this hypothesis, we measured isometric force displacement in isolated rat pulmonary artery rings during hypoxia in the presence and absence of the selective p38 MAP kinase inhibitor SB-20358, and stimulator anisomycin. In separate experiments, we measured the functional effects in isolated rat pulmonary artery rings of inhibiting p38 MAP kinase during normoxic conditions. p38 MAP kinase inhibition significantly attenuated the delayed, but not early, contractile phase of HPV. Additionally, stimulation of p38 MAP kinase significantly decreased the phase I vasodilation of HPV. Under normoxia conditions, there was no statistically significant difference in isometric force displacement between control and p38 MAPK inhibitor-treated pulmonary artery rings. We conclude that p38 MAP kinase may be a key mediator in the pathogenesis of HPV and that further understanding may lead to new therapies for HPV associated with acute lung injury.

Original languageEnglish
Pages (from-to)335-341
Number of pages7
JournalJournal of Surgical Research
Volume134
Issue number2
DOIs
StatePublished - Aug 2006

Fingerprint

p38 Mitogen-Activated Protein Kinases
Vasoconstriction
Vasodilation
Lung
Pulmonary Artery
Anisomycin
Acute Lung Injury
Protein Kinase Inhibitors
Pulmonary Hypertension
Thorax
Transplants
Wounds and Injuries

Keywords

  • hypoxia
  • lung physiology
  • p38 MAP kinase
  • pulmonary arteries

ASJC Scopus subject areas

  • Surgery

Cite this

p38 Mitogen-Activated Protein Kinase Mediates the Sustained Phase of Hypoxic Pulmonary Vasoconstriction and Plays a Role in Phase I Vasodilation. / Morrell, Eric D.; Tsai, Ben M.; Wang, Meijing; Crisostomo, Paul R.; Meldrum, Daniel R.

In: Journal of Surgical Research, Vol. 134, No. 2, 08.2006, p. 335-341.

Research output: Contribution to journalArticle

@article{eee217db6c724f45bbbcf30806a8008a,
title = "p38 Mitogen-Activated Protein Kinase Mediates the Sustained Phase of Hypoxic Pulmonary Vasoconstriction and Plays a Role in Phase I Vasodilation",
abstract = "Hypoxic pulmonary vasoconstriction (HPV) and pulmonary hypertension present common and formidable clinical problems for thoracic, transplant, and trauma surgeons. We hypothesized that acute hypoxia causes pulmonary artery (PA) contraction and that p38 mitogen-activated protein (MAP) kinase is a key mediator in that process. To test this hypothesis, we measured isometric force displacement in isolated rat pulmonary artery rings during hypoxia in the presence and absence of the selective p38 MAP kinase inhibitor SB-20358, and stimulator anisomycin. In separate experiments, we measured the functional effects in isolated rat pulmonary artery rings of inhibiting p38 MAP kinase during normoxic conditions. p38 MAP kinase inhibition significantly attenuated the delayed, but not early, contractile phase of HPV. Additionally, stimulation of p38 MAP kinase significantly decreased the phase I vasodilation of HPV. Under normoxia conditions, there was no statistically significant difference in isometric force displacement between control and p38 MAPK inhibitor-treated pulmonary artery rings. We conclude that p38 MAP kinase may be a key mediator in the pathogenesis of HPV and that further understanding may lead to new therapies for HPV associated with acute lung injury.",
keywords = "hypoxia, lung physiology, p38 MAP kinase, pulmonary arteries",
author = "Morrell, {Eric D.} and Tsai, {Ben M.} and Meijing Wang and Crisostomo, {Paul R.} and Meldrum, {Daniel R.}",
year = "2006",
month = "8",
doi = "10.1016/j.jss.2006.01.028",
language = "English",
volume = "134",
pages = "335--341",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - p38 Mitogen-Activated Protein Kinase Mediates the Sustained Phase of Hypoxic Pulmonary Vasoconstriction and Plays a Role in Phase I Vasodilation

AU - Morrell, Eric D.

AU - Tsai, Ben M.

AU - Wang, Meijing

AU - Crisostomo, Paul R.

AU - Meldrum, Daniel R.

PY - 2006/8

Y1 - 2006/8

N2 - Hypoxic pulmonary vasoconstriction (HPV) and pulmonary hypertension present common and formidable clinical problems for thoracic, transplant, and trauma surgeons. We hypothesized that acute hypoxia causes pulmonary artery (PA) contraction and that p38 mitogen-activated protein (MAP) kinase is a key mediator in that process. To test this hypothesis, we measured isometric force displacement in isolated rat pulmonary artery rings during hypoxia in the presence and absence of the selective p38 MAP kinase inhibitor SB-20358, and stimulator anisomycin. In separate experiments, we measured the functional effects in isolated rat pulmonary artery rings of inhibiting p38 MAP kinase during normoxic conditions. p38 MAP kinase inhibition significantly attenuated the delayed, but not early, contractile phase of HPV. Additionally, stimulation of p38 MAP kinase significantly decreased the phase I vasodilation of HPV. Under normoxia conditions, there was no statistically significant difference in isometric force displacement between control and p38 MAPK inhibitor-treated pulmonary artery rings. We conclude that p38 MAP kinase may be a key mediator in the pathogenesis of HPV and that further understanding may lead to new therapies for HPV associated with acute lung injury.

AB - Hypoxic pulmonary vasoconstriction (HPV) and pulmonary hypertension present common and formidable clinical problems for thoracic, transplant, and trauma surgeons. We hypothesized that acute hypoxia causes pulmonary artery (PA) contraction and that p38 mitogen-activated protein (MAP) kinase is a key mediator in that process. To test this hypothesis, we measured isometric force displacement in isolated rat pulmonary artery rings during hypoxia in the presence and absence of the selective p38 MAP kinase inhibitor SB-20358, and stimulator anisomycin. In separate experiments, we measured the functional effects in isolated rat pulmonary artery rings of inhibiting p38 MAP kinase during normoxic conditions. p38 MAP kinase inhibition significantly attenuated the delayed, but not early, contractile phase of HPV. Additionally, stimulation of p38 MAP kinase significantly decreased the phase I vasodilation of HPV. Under normoxia conditions, there was no statistically significant difference in isometric force displacement between control and p38 MAPK inhibitor-treated pulmonary artery rings. We conclude that p38 MAP kinase may be a key mediator in the pathogenesis of HPV and that further understanding may lead to new therapies for HPV associated with acute lung injury.

KW - hypoxia

KW - lung physiology

KW - p38 MAP kinase

KW - pulmonary arteries

UR - http://www.scopus.com/inward/record.url?scp=33746253900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746253900&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2006.01.028

DO - 10.1016/j.jss.2006.01.028

M3 - Article

C2 - 16542681

AN - SCOPUS:33746253900

VL - 134

SP - 335

EP - 341

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -